CXCL11 is a chemokine known to mediate the migration of activated T-cells, and has been described as an immunomodulatory target of miRNA in primary lymphoma and has also demonstrated potent antitumor activity in an animal model [38], [39]. This evidence concerns the gene CXCL11 and lymphoma.